|
MARCKS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.154150E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.043170E-01 |
| Normal-vs-Stage2 |
8.737000E-01 |
| Normal-vs-Stage3 |
4.057400E-01 |
| Normal-vs-Stage4 |
1.109560E-01 |
| Stage1-vs-Stage2 |
2.221400E-01 |
| Stage1-vs-Stage3 |
7.354400E-01 |
| Stage1-vs-Stage4 |
4.783600E-01 |
| Stage2-vs-Stage3 |
4.737600E-01 |
| Stage2-vs-Stage4 |
1.739350E-01 |
| Stage3-vs-Stage4 |
4.414400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.439900E-02 |
| Normal-vs-AfricanAmerican |
7.649800E-01 |
| Normal-vs-Asian |
8.867600E-01 |
| Caucasian-vs-AfricanAmerican |
7.120200E-01 |
| Caucasian-vs-Asian |
4.273400E-01 |
| AfricanAmerican-vs-Asian |
8.652600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.978400E-01 |
| Normal-vs-Female |
1.153600E-01 |
| Male-vs-Female |
8.136600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.755600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.073610E-02 |
| Normal-vs-Age(61-80Yrs) |
7.326200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.898600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.253400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.625800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.114200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.658830E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.985600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.758400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.338200E-01 |
| Classical-VS-Follicular |
1.245760E-01 |
| Classical-VS-Other |
9.745000E-01 |
| Classical-VS-Normal |
4.920500E-02 |
| Tall-VS-Follicular |
8.211800E-01 |
| Tall-VS-Other |
6.684600E-01 |
| Tall-VS-Normal |
8.580400E-01 |
| Follicular-VS-Other |
6.642600E-01 |
| Follicular-VS-Normal |
9.526400E-01 |
| Other-VS-Normal |
7.041200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.603800E-01 |
| Normal-vs-N1 |
3.119800E-02 |
| N0-vs-N1 |
1.494570E-01 |
|
|
